Hyperkalemia is an electrolyte abnormality with potentially life-threatening consequences.
Despite various guidelines, no universally accepted consensus exists on best practices for …

In patients with heart failure (HF), the neuroendocrine systems of the sympathetic nervous
system (SNS), the renin–angiotensin–aldosterone system (RAAS) and the arginine …

Kidney disease, blood pressure determination, hypertension pathogenesis, and the renin-
angiotensin system (RAS) are inextricably linked. Hence, understanding the RAS is pivotal …

The increasing number of patients with heart failure HF and comorbidities is due to aging
population and increase of life expectancy of patients with cardiovascular disease …

Background Although previous clinical randomized controlled trials (RCTs) have tested the
effect of a variety of cardioprotective agents on cancer therapy-induced cardiotoxicity, the …

Background It has long been suggested that angiotensin‐converting enzyme inhibitors (ACE
i) and angiotensin II receptor blockers (AT 2s) have some degree of 'cross‐reactivity'in …

Heart failure (HF) is emerging as an important public health problem in India. With the dual
burden of traditional diseases like rheumatic heart diseases and the rising burden of new …

Several compounds have been used for atherosclerosis treatment, including clinical trials;
however, no anti-atherosclerotic drugs based on hemodynamic force-mediated …

Arterial hypertension is the main preventable cause of premature mortality worldwide.
Across Latin America, hypertension has an estimated prevalence of 25.5–52.5%, although …

Angiotensin-converting enzyme (ACE) inhibitors, which prevent the conversion of
angiotensin I to angiotensin II, are well-known for the treatments of cardiovascular diseases …